Sutro Biopharma IncNASDAQ:STRO
- LAST PRICE3.6300
- TODAY'S CHANGE (%)-0.1400 (-3.7135%)
- Bid / Lots3.3900/ 3
- Ask / Lots4.1000/ 1
- Open / Previous Close3.7300 / 3.7700
- Day Range
- 52 Week Range
- Volume515,911
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | STRO |
|---|---|---|
| 09:32 ET | 17274 | 3.745 |
| 09:34 ET | 512 | 3.79 |
| 09:36 ET | 800 | 3.79 |
| 09:38 ET | 2200 | 3.76 |
| 09:39 ET | 100 | 3.74 |
| 09:41 ET | 4633 | 3.74 |
| 09:43 ET | 4550 | 3.76 |
| 09:45 ET | 700 | 3.76 |
| 09:48 ET | 1604 | 3.78 |
| 09:50 ET | 900 | 3.77 |
| 09:52 ET | 5225 | 3.77 |
| 09:54 ET | 387 | 3.76 |
| 09:56 ET | 2800 | 3.755 |
| 09:57 ET | 400 | 3.74 |
| 09:59 ET | 1036 | 3.73 |
| 10:01 ET | 500 | 3.7225 |
| 10:03 ET | 576 | 3.73 |
| 10:06 ET | 800 | 3.745 |
| 10:08 ET | 1773 | 3.75 |
| 10:12 ET | 981 | 3.73 |
| 10:14 ET | 524 | 3.725 |
| 10:15 ET | 1350 | 3.725 |
| 10:17 ET | 1846 | 3.745 |
| 10:19 ET | 400 | 3.725 |
| 10:21 ET | 1344 | 3.735 |
| 10:24 ET | 1800 | 3.745 |
| 10:26 ET | 700 | 3.74 |
| 10:28 ET | 100 | 3.735 |
| 10:30 ET | 1134 | 3.74 |
| 10:32 ET | 4550 | 3.765 |
| 10:33 ET | 1419 | 3.75 |
| 10:35 ET | 830 | 3.75 |
| 10:37 ET | 1377 | 3.74 |
| 10:39 ET | 4146 | 3.745 |
| 10:42 ET | 100 | 3.745 |
| 10:44 ET | 4125 | 3.75 |
| 10:46 ET | 823 | 3.745 |
| 10:48 ET | 800 | 3.75 |
| 10:50 ET | 500 | 3.74 |
| 10:51 ET | 402 | 3.735 |
| 10:53 ET | 700 | 3.735 |
| 10:55 ET | 200 | 3.735 |
| 10:57 ET | 705 | 3.725 |
| 11:00 ET | 2227 | 3.725 |
| 11:02 ET | 1866 | 3.715 |
| 11:04 ET | 2885 | 3.69 |
| 11:06 ET | 133 | 3.695 |
| 11:08 ET | 500 | 3.69 |
| 11:09 ET | 900 | 3.695 |
| 11:11 ET | 300 | 3.695 |
| 11:13 ET | 5050 | 3.715 |
| 11:15 ET | 100 | 3.72 |
| 11:18 ET | 1883 | 3.715 |
| 11:20 ET | 300 | 3.71 |
| 11:22 ET | 1922 | 3.705 |
| 11:24 ET | 427 | 3.7 |
| 11:26 ET | 1200 | 3.685 |
| 11:27 ET | 600 | 3.675 |
| 11:29 ET | 940 | 3.6625 |
| 11:31 ET | 1912 | 3.665 |
| 11:33 ET | 700 | 3.665 |
| 11:36 ET | 200 | 3.665 |
| 11:38 ET | 6059 | 3.67 |
| 11:40 ET | 630 | 3.675 |
| 11:42 ET | 502 | 3.675 |
| 11:44 ET | 498 | 3.675 |
| 11:45 ET | 2718 | 3.68 |
| 11:47 ET | 2099 | 3.695 |
| 11:49 ET | 3000 | 3.705 |
| 11:51 ET | 200 | 3.71 |
| 11:54 ET | 1100 | 3.705 |
| 11:56 ET | 4127 | 3.717 |
| 11:58 ET | 2255 | 3.705 |
| 12:00 ET | 420 | 3.7 |
| 12:02 ET | 372 | 3.7 |
| 12:03 ET | 200 | 3.7 |
| 12:05 ET | 100 | 3.695 |
| 12:07 ET | 1710 | 3.694 |
| 12:09 ET | 7300 | 3.695 |
| 12:12 ET | 2811 | 3.665 |
| 12:14 ET | 2126 | 3.67 |
| 12:16 ET | 400 | 3.66 |
| 12:18 ET | 414 | 3.665 |
| 12:20 ET | 2370 | 3.6699 |
| 12:25 ET | 6402 | 3.6588 |
| 12:30 ET | 200 | 3.66 |
| 12:32 ET | 704 | 3.655 |
| 12:34 ET | 200 | 3.66 |
| 12:36 ET | 100 | 3.655 |
| 12:38 ET | 683 | 3.655 |
| 12:39 ET | 2058 | 3.665 |
| 12:41 ET | 100 | 3.67 |
| 12:43 ET | 4391 | 3.675 |
| 12:45 ET | 200 | 3.677 |
| 12:48 ET | 200 | 3.68 |
| 12:50 ET | 200 | 3.675 |
| 12:52 ET | 1100 | 3.679 |
| 12:54 ET | 3341 | 3.675 |
| 12:56 ET | 300 | 3.68 |
| 12:57 ET | 200 | 3.675 |
| 12:59 ET | 300 | 3.68 |
| 01:01 ET | 400 | 3.68 |
| 01:03 ET | 485 | 3.67 |
| 01:06 ET | 700 | 3.675 |
| 01:08 ET | 955 | 3.675 |
| 01:10 ET | 400 | 3.67 |
| 01:12 ET | 200 | 3.68 |
| 01:14 ET | 300 | 3.68 |
| 01:17 ET | 1311 | 3.675 |
| 01:19 ET | 2023 | 3.68 |
| 01:21 ET | 300 | 3.675 |
| 01:24 ET | 408 | 3.675 |
| 01:26 ET | 100 | 3.68 |
| 01:28 ET | 1500 | 3.68 |
| 01:30 ET | 7267 | 3.655 |
| 01:32 ET | 100 | 3.655 |
| 01:33 ET | 3691 | 3.625 |
| 01:35 ET | 2158 | 3.6008 |
| 01:37 ET | 443 | 3.6 |
| 01:39 ET | 1190 | 3.6041 |
| 01:42 ET | 7298 | 3.615 |
| 01:44 ET | 2007 | 3.615 |
| 01:46 ET | 200 | 3.615 |
| 01:48 ET | 100 | 3.62 |
| 01:50 ET | 2949 | 3.63 |
| 01:51 ET | 100 | 3.63 |
| 01:53 ET | 100 | 3.63 |
| 01:55 ET | 1100 | 3.625 |
| 01:57 ET | 6322 | 3.62 |
| 02:00 ET | 481 | 3.62 |
| 02:02 ET | 5009 | 3.615 |
| 02:04 ET | 933 | 3.61 |
| 02:06 ET | 200 | 3.6 |
| 02:08 ET | 184 | 3.6012 |
| 02:11 ET | 563 | 3.6 |
| 02:13 ET | 6883 | 3.605 |
| 02:15 ET | 217 | 3.61 |
| 02:18 ET | 200 | 3.605 |
| 02:20 ET | 1227 | 3.61 |
| 02:22 ET | 681 | 3.605 |
| 02:24 ET | 618 | 3.61 |
| 02:26 ET | 8213 | 3.59 |
| 02:27 ET | 2328 | 3.575 |
| 02:29 ET | 270 | 3.57 |
| 02:31 ET | 5692 | 3.565 |
| 02:33 ET | 200 | 3.56 |
| 02:36 ET | 6107 | 3.575 |
| 02:38 ET | 100 | 3.575 |
| 02:40 ET | 2322 | 3.56 |
| 02:44 ET | 700 | 3.55 |
| 02:47 ET | 3321 | 3.555 |
| 02:49 ET | 4399 | 3.565 |
| 02:51 ET | 2400 | 3.565 |
| 02:54 ET | 100 | 3.57 |
| 02:56 ET | 2600 | 3.565 |
| 02:58 ET | 386 | 3.565 |
| 03:00 ET | 800 | 3.57 |
| 03:02 ET | 300 | 3.565 |
| 03:03 ET | 1128 | 3.565 |
| 03:05 ET | 2400 | 3.575 |
| 03:07 ET | 1202 | 3.575 |
| 03:09 ET | 1200 | 3.5797 |
| 03:12 ET | 544 | 3.58 |
| 03:14 ET | 7637 | 3.58 |
| 03:16 ET | 583 | 3.575 |
| 03:18 ET | 200 | 3.58 |
| 03:20 ET | 574 | 3.575 |
| 03:21 ET | 7135 | 3.575 |
| 03:23 ET | 3052 | 3.58 |
| 03:25 ET | 2000 | 3.5799 |
| 03:27 ET | 1044 | 3.575 |
| 03:30 ET | 200 | 3.5725 |
| 03:32 ET | 519 | 3.5725 |
| 03:34 ET | 1366 | 3.58 |
| 03:36 ET | 3170 | 3.59 |
| 03:38 ET | 1704 | 3.59 |
| 03:39 ET | 980 | 3.6 |
| 03:41 ET | 635 | 3.595 |
| 03:43 ET | 1936 | 3.59 |
| 03:45 ET | 704 | 3.595 |
| 03:48 ET | 11271 | 3.615 |
| 03:50 ET | 15239 | 3.635 |
| 03:52 ET | 6427 | 3.64 |
| 03:54 ET | 2857 | 3.64 |
| 03:56 ET | 13479 | 3.635 |
| 03:57 ET | 8272 | 3.635 |
| 03:59 ET | 9980 | 3.63 |
Apr 3, 2024
DJ Sutro Biopharma Price Target Cut to $11.00/Share From $12.00 by Piper Sandler, from 11:45AM ET on Wednesday Apr 03, 2024 by Dow Jones
11:45AM ET on Wednesday Apr 03, 2024 by Dow JonesDJ Sutro Biopharma Is Maintained at Outperform by Oppenheimer, from 10:16AM ET on Wednesday Apr 03, 2024 by Dow Jones
10:16AM ET on Wednesday Apr 03, 2024 by Dow JonesDJ Sutro Biopharma Is Maintained at Buy by Truist Securities, from 9:43AM ET on Wednesday Apr 03, 2024 by Dow Jones
9:43AM ET on Wednesday Apr 03, 2024 by Dow JonesDJ Sutro Biopharma Price Target Maintained With a $17.00/Share by JMP Securities, from 8:34AM ET on Wednesday Apr 03, 2024 by Dow Jones
8:34AM ET on Wednesday Apr 03, 2024 by Dow Jones
Apr 2, 2024
Sutro Biopharma Announces Pricing of $75 Million Underwritten Offering, from 6:18AM ET on Tuesday Apr 02, 2024 by Dow Jones
6:18AM ET on Tuesday Apr 02, 2024 by Dow Jones
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
Sutro Biopharma Inc | 274.0M | -2.0x | --- |
Kamada Ltd | 290.2M | 28.7x | -22.48% |
Avid Bioservices Inc | 404.1M | -35.2x | --- |
Adaptive Biotechnologies Corp | 348.2M | -1.5x | --- |
Agenus Inc | 111.2M | -0.4x | --- |
Anika Therapeutics Inc | 378.3M | -4.6x | --- |
Company Information
Sutro Biopharma, Inc. is a clinical-stage oncology company. The Company is engaged in developing site-specific and novel-format antibody drug conjugates (ADCs) enabled by its integrated cell-free protein synthesis platform, XpressCF, and its site-specific conjugation platform, XpressCF+. The Company’s advanced product candidate is STRO-002 (luveltamab tazevibulin, or luvelta), an ADC directed against folate receptor-alpha (FolRa), for patients with FolRa-expressing cancers, including ovarian cancer. In addition, it uses luvelta to treat pediatric patients with relapsed/refractory CBFA2T3-GLIS2 and acute myeloid leukemia. It also has two preclinical product candidates, STRO-003 and STRO-004. These product candidates are single homogeneous ADCs directed against an anti-receptor tyrosine kinase-like orphan receptor 1 (ROR1), and tissue factor (TF), each of which is being developed for the treatment of solid tumors.
Contact Information
- Headquarters
- 111 Oyster Point Blvd.SOUTH SAN FRANCISCO, CA, United States 94080
- Phone
- 650-392-8412
- Fax
- 302-655-5049
Executives
- Independent Chairman of the Board
- Connie Matsui
- President, Chief Operating Officer
- Jane Chung
- Chief Executive Officer, Director
- William Newell
- Chief Financial Officer
- Edward Albini
- Chief People and Communications Officer
- Linda Fitzpatrick
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $274.0M |
|---|---|
Revenue (TTM) | $153.7M |
Shares Outstanding | 75.5M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 1.09 |
EPS | $-1.79 |
Book Value | $2.45 |
P/E Ratio | -2.0x |
Price/Sales (TTM) | 1.8 |
Price/Cash Flow (TTM) | --- |
Operating Margin | -58.07% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
